Dysplasia and aberrant methylation profiles in risk and lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 458s Year: 2005
Aberrant methylation in lung cancer identified by EBUS-TBNA as a marker of advanced staging Source: Annual Congress 2012 - Progress in endoscopy for lung cancer Year: 2012
Aberrant promoter methylation in sputum and bronchial washing in patients at risk for lung cancer Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009
Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival. Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018
Loss of heterozygosity detected in plasma DNA of early stage lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 673s Year: 2004
Features affecting stages of patients with lung cancer at diagnosis Source: Eur Respir J 2005; 26: Suppl. 49, 536s Year: 2005
The role of P53 tumor suppressor gene mutations in early diagnosis of lung cancer among patients with solitary pulmonary nodule Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009
Detection of aberrant methylation of p16(INK4a) and MGMT in endobronchial specimens increases the diagnostic yield in cases of suspected peripheral lung carcinomas Source: Eur Respir J 2002; 20: Suppl. 38, 2s Year: 2002
Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathological characteristics of primary non small cell lung carcinoma Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
Profile of WT1 methylation in human lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
Early detection of lung cancer: role of biomarkers Source: Eur Respir J 2003; 21: 36S-44S Year: 2003
DNA methylation and gene expression changes in human lung fibroblasts occur already in mild COPD and progress with disease development Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018
Characteristics and prognostic relevance of p 53 gene mutations in Polish non small cell lung cancer (NSCLC) patients Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005
DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013
Hypermethylation pattern in genomic DNA samples derived from tumor and serum of resected non-small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004
Clinical evaluation of the plasma levels of hTERT and EGFR expression as markers for early detection of non-small cell lung cancer Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009
Early proximal lung cancer diagnosis and treatment Source: Eur Respir J 2009; 33: 656-665 Year: 2009
RARβ2 methylation level in blood for lung cancer assessment Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011
Quantification of telomerase activity is important in predicting prognosis of patients with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 482s Year: 2005